Login  /  Register  | 3 premium articles left before you must register.

FDA to weigh new use for Amarin drug

Published June 20. 2013 4:00AM

Amarin Corp. plc, the Irish biotech with R&D headquarters in Groton, announced Wednesday that the U.S. Food and Drug Administration will convene an advisory committee Oct. 16 to consider a supplemental new drug application for heart pill Vascepa.

The advisory committee is expected to vote on whether to recommend the approval of Vascepa for people with elevated levels of fat in their blood who do not currently have a prescription option for lowering heart-clogging triglycerides. Vascepa is currently approved only for people with dangerous triglyceride levels.

FDA is expected to complete its review of Vascepa for the new indication by Dec. 20.

News by Town

Most Recent Poll
Does your neighbor's lawn mowing annoy you?
As long as it's not early in the morning or late at night, people should cut their lawns when they want.
58%
People don't have any regard for their neighbors' wishes anymore.
8%
It could be worse, you could have a motorbike track next door.
8%
I actually like the sound of a lawnmover. It's the sound of summer.
26%
Number of votes: 1293

No current items found